NCT01353209 2024-04-17
TRAIL
University of Cincinnati
Phase 2 Completed
Clinical Trials
16 trialsNCT00414648 2023-11-02
MILES
University of Cincinnati
Phase 3 Completed
NCT05323370 2023-03-29
LAM-CAK
University Hospital, Tours
Completed
NCT03253913 2023-02-01
RESULT
University of Cincinnati
Phase 2 Completed
NCT02325505 2022-08-04
Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
InCor Heart Institute
Completed
NCT02484664 2022-01-20
COLA
Brigham and Women's Hospital
Phase 2 Completed
NCT02061397 2020-08-25
SOS
University of Pennsylvania
Phase 1/2 Completed
NCT03131999 2020-06-16
LAMP-1
Medical University of South Carolina
Phase 1/2 Completed
NCT04184193 2020-01-21
Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)
Schön Klinik Berchtesgadener Land
Completed
NCT01687179 2018-10-11
SAIL
Brigham and Women's Hospital
Phase 1 Completed
NCT02859194 2018-07-18
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients
Yonsei University
Phase NA Completed
NCT02116712 2016-11-30
The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Baylor College of Medicine
Phase 1 Completed
NCT02009241 2015-12-11
Pulmonary Rehabilitation in Lymphangioleiomyomatosis
University of Sao Paulo General Hospital
Phase NA Completed
NCT00989742 2015-12-02
Doxycycline In Lymphangioleiomyomatosis (LAM)
University of Nottingham
Phase 4 Completed
NCT00960895 2011-10-27
LAM-PH
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Completed
NCT00457808 2007-04-09
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati
Phase 2 Completed